Bryan Morton has over 30 years’ experience as a successful entrepreneur and senior manager in the pharmaceutical industry. Morton was previously CEO of EUSA Pharma, a global speciality oncology company, which was acquired by Jazz Pharmaceuticals in 2012 for $700 million.